In a real-world study, researchers found this data by comparing treatment patterns, healthcare resource utilization, and ...

Wojciech Jurczak, MD, PhD, ​​discusses the future of B-cell lymphoma therapy, with a focus on Bruton's tyrosine kinase ...

Wojciech Jurczak, MD, PhD, discusses advancements in B-cell lymphoma therapy, focusing on immunotherapy, molecular-targeted agents, and more.

There are currently dozens of clinical trials examining new ways to treat mantle cell lymphoma (MCL). People can learn about trial recruitment at ClinicalTrials.gov. Research into mantle cell ...

An app told Brian O'Sullivan he had cancer. 'And that started my love-hate relationship with technology,' he says.

This approval augments Biocon Pharma's complex injectables portfolio and reinforces its footprint in the US pharma market.

They're both slow-growing, and you treat them the same way. The only difference is where these cancers start: Mantle cell lymphoma (MCL) is a rare and fast-growing cancer. About 6% of all non ...

Bristol Myers Squibb gets European Commission approval to expand use of CAR T cell therapy, Breyanzi for relapsed or refractory follicular lymphoma: Princeton, New Jersey Monday, ...

The diagnosis: a rare blood cancer called mantle cell lymphoma. “So, the app told me what type of cancer I had, not a doctor. And that started my love-hate relationship with technology,” said ...